Coronavirus infection disease (COVID-19) is a recent pandemic infectious disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2). COVID-19 is associated with different neurological manifestations, as one-third of COVID-19 patients have some neurological disorders, including paraesthesia, headache, cold extremities and disturbances of consciousness, that are more evident in severely affected patients. The entry of SARS-CoV-2 into human host cells is mediated mainly by the cellular receptor angiotensin-converting enzyme 2 (ACE2), which is expressed at very low levels in the CNS under normal conditions. The dissemination of COVID-19 in the systemic circulation or across the cribriform plate of the ethmoid bone during an early or later phase of the infection can lead to cerebral involvement as has been reported in the past for SARS-CoV affected patients. COVID‐19‐related CNS dysfunction results from direct viral injury, indirect consequences of immune‐mediated disease, systemic effects of infection, or local effects of the virus is still a matter of debate and these hypotheses are not mutually exclusive.